Literature DB >> 24706677

ctDNA is a specific and sensitive biomarker in multiple human cancers.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24706677     DOI： 10.1158/2159-8290.CD-RW2014-051

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


× No keyword cloud information.
  4 in total

1.  Statistical analysis of mutant allele frequency level of circulating cell-free DNA and blood cells in healthy individuals.

Authors:  Ligang Xia; Zhoufang Li; Bo Zhou; Geng Tian; Lidong Zeng; Hongyu Dai; Xiaohua Li; Chaoyu Liu; Shixin Lu; Feiyue Xu; Xiaonian Tu; Fang Deng; Yuancai Xie; Weiren Huang; Jiankui He
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

2.  Mutation analysis of circulating tumor DNA and paired ascites and tumor tissues in ovarian cancer.

Authors:  Xiaoxiang Jie; Ming Du; Meng Zhang; Xiayu Jin; Qingqing Cai; Congjian Xu; Xiaoyan Zhang
Journal:  Exp Ther Med       Date:  2022-06-30       Impact factor: 2.751

3.  Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay.

Authors:  Maria Schwaederle; Hatim Husain; Paul T Fanta; David E Piccioni; Santosh Kesari; Richard B Schwab; Kimberly C Banks; Richard B Lanman; AmirAli Talasaz; Barbara A Parker; Razelle Kurzrock
Journal:  Oncotarget       Date:  2016-03-01

4.  Sensitive Biomarker Analysis of Xue-Fu-Zhu-Yu Capsule for Patients with Qi Stagnation and Blood Stasis Pattern: A Nested Case-Control Study.

Authors:  Guang Chen; Haoqiang He; Kun Hu; Jialiang Gao; Jun Li; Mei Han; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-18       Impact factor: 2.629
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.